PayPay Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9K Buy
207
+169
+445% +$9.7K 0.29% 53
2026
Q1
$2.24K Sell
38
-10
-21% -$583 0.08% 163
2025
Q4
$2.59K Buy
48
+10
+26% +$481 0.08% 165
2025
Q3
$1.73K Sell
38
-21
-36% -$981 0.06% 181
2025
Q2
$2.73K Buy
59
+15
+34% +$736 0.13% 111
2025
Q1
$2.72K Sell
44
-13
-23% -$758 0.16% 128
2024
Q4
$3.22K Buy
57
+2
+4% +$112 0.14% 125
2024
Q3
$2.85K Sell
55
-4
-7% -$188 0.25% 81
2024
Q2
$2.45K Buy
59
+10
+20% +$447 0.2% 120
2024
Q1
$2.66K Sell
49
-6
-11% -$306 0.13% 149
2023
Q4
$2.83K Buy
55
+11
+25% +$577 0.14% 147
2023
Q3
$2.55K Hold
44
0.12% 136
2023
Q2
$2.81K Sell
44
-12
-21% -$805 0.17% 92
2023
Q1
$3.88K Sell
56
-43
-43% -$3.03K 0.26% 91
2022
Q4
$7.12K Buy
+99
New +$7.46K 0.48% 53

Other funds holding BMY

PayPay Securities's BMY Position: Q2 2026 in Review

PayPay Securities increased its Bristol-Myers Squibb (BMY) stake by 445% in Q2 2026, buying an estimated $9.7K and bringing the position to 207 shares worth $11.9K. The position accounts for 0.29% of the portfolio, ranked #53.

PayPay Securities first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • PayPay Securities held 207 shares of Bristol-Myers Squibb worth $11.9K as of Q2 2026.
  • PayPay Securities bought 169 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.7K.
  • Bristol-Myers Squibb made up 0.29% of PayPay Securities's portfolio in Q2 2026, its #53 holding.
  • PayPay Securities first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.